Durable responses and low toxicity after fast off-rate cd19 chimeric antigen receptor-t therapy in adults with relapsed or refractory b-cell acute lymphoblastic leukemia
Claire Roddie, Juliana Dias, Maeve A. O'Reilly, Mahnaz Abbasian, Amaia Cadinanos-Garai, Ketki Vispute, Leticia Bosshard-Carter, Marina Mitsikakou, Vedika Mehra, Harriet Roddy, John A. Hartley, Victoria Spanswick, Helen Lowe, Bilyana Popova, Laura Clifton-Hadley, Graham Wheeler, Joanna Olejnik, Adrian Bloor, David Irvine, Leigh WoodMaria A.V. Marzolini, Sabine Domning, Farzin Farzaneh, Mark W. Lowdell, David C. Linch, Martin A. Pule*, Karl S. Peggs
Research output: Contribution to journal › Article › peer-review
71Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Durable responses and low toxicity after fast off-rate cd19 chimeric antigen receptor-t therapy in adults with relapsed or refractory b-cell acute lymphoblastic leukemia'. Together they form a unique fingerprint.